Back to top
more

Mesa Laboratories (MLAB)

(Delayed Data from NSDQ)

$126.18 USD

126.18
19,544

+3.70 (3.02%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $125.71 -0.47 (-0.37%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (96 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

McKesson (MCK) Misses Earnings Estimates in Q1, Raises View

McKesson's (MCK) performance was muted in the first quarter owing to branded to generic conversions and competition in its pharmacy business.

    Integra LifeSciences (IART) Q2 Earnings Meet, Revenues Miss

    Integra LifeSciences' (IART) solid performance in the Orthopedics and Tissue Technologies was the key highlight of the second quarter.

      CONMED (CNMD) Earnings Meet, Revenues Beat Estimates in Q2

      CONMED's (CNMD) strong global performance was a key highlight in the second quarter of 2017.

        LabCorp (LH) Beats on Q2 Earnings and Sales, Guidance Up

        LabCorp's (LH) dull Covance Drug Development performance is offset by solid growth in Diagnostics. Increased guidance raises hope.

          Chemed (CHE) Q2 Earnings & Revenues Rise Y/Y, View Revised

          Chemed (CHE) rides high on Roto-Rooter in second-quarter 2017. An encouraging bottom-line projection raises hopes.

            PetMed Express (PETS) Tops Earnings, Revenue Estimates in Q1

            PetMed (PETS) initiated fiscal 2018 with better-than-expected results in the first quarter, beating both earnings and revenues.

              Abbott Labs (ABT) Beats on Q2 Earnings and Sales, View Up

              Abbott Labs' (ABT) Q2 performance was strong on solid EPD and Medical Device growth. The stock's guidance for 2017 has also been raised.

                Quest Diagnostics Closes Deal to Acquire 2 Labs in Texas

                Quest Diagnostics (DGX) acquires Med Fusion and Clear Point lab businesses to grow in oncology space.

                  Align Technology Hits a 52-Week High on Solid Prospects

                  Share price of San Jose, CA-based Align Technology, Inc. (ALGN) reached a new 52-week high of $157.86 on Jul 17, eventually closing a bit lower at $156.21.

                    Medtronic InterStim System Shows Five-Year Positive Results

                    Medtronic plc (MDT) has announced that its InterStim system provides sustained long-term efficacy and improved quality of life for overactive bladder (OAB) patients at the end of five years.

                      Haemonetics Plasma Arm Advances, Blood Center Sluggish

                      On Jul 13, we issued an updated research report on Haemonetics Corporation (HAE).

                        Why Is It the Perfect Time to Buy Thermo Fisher (TMO) Stock?

                        Thermo Fisher Scientific, Inc. (TMO) is on a healthy growth trajectory of late and has rallied 17.7% over the past three months.

                          BioTelemetry (BEAT) Acquires LifeWatch for $280 Million

                          BioTelemetry Inc. (BEAT) enhances its position in the wireless medicine space, enlarges product profile and customer base in cardiac monitoring and diagnostic services with LifeWatch buyout.

                            Hill-Rom (HRC) at 52-Week High: What's Driving the Stock?

                            Share price of Batesville, IN-based Hill-Rom Holdings, Inc. (HRC) scaled a new 52-week high of $84.17 on Jul 14.

                              Avantor to Acquire VWR, Consolidation Promises Global Gains

                              On Jul 14, we issued an updated research report on Radnor, PA-based VWR Corporation (VWR).

                                DaVita Medical Group Buys Dr. Rahn Shaw Practices in Orlando

                                DaVita Inc. (DVA) recently acquired Dr. Rahn Shaw's practices, Park Avenue Medical, Inc. and Winter Park Health Center, Inc., each located in Orlando.

                                  Abiomed (ABMD) Scores a Strong Buy Right Now: Here's How

                                  With solid growth prospects Abiomed (ABMD) carries a Zacks Rank #1 (Strong Buy) which is an attractive pick at present.

                                    Medtronic Enrolls First Patient Under STOP AF First Trial

                                    Medtronic (MDT) recently announced the first enrollment to its STOP AF First clinical trial.

                                      Edwards Emerges Strong on FDA Nods, International Prospect

                                      On Jul 11, we issued an updated research report on the leading molecular diagnostic company, Edwards Lifesciences Corporation (EW).

                                        Here's Why You Should Add ResMed to Your Portfolio Now

                                        California-based ResMed, Inc. (RMD) has been on a healthy growth trajectory of late.

                                          CVS Health's MinuteClinic Joins EOHN for Workplace Healthcare

                                          MinuteClinic, the retail medical clinic of CVS Health Corporation (CVS), announced a tie-up with the Alere eScreen Occupational Health Network.

                                            Express Scripts Rides High on Increased Generic Utilization

                                            On Jul 10, we issued an updated research report on St. Louis, MO-based pharmacy benefit manager Express Scripts Holding Company (ESRX).

                                              PAREXEL (PRXL) Gets CEO Cancer Gold Standard Accreditation

                                              PAREXEL International Corporation (PRXL) was recently nominated as a CEO Cancer Gold Standard employer by CEO Roundtable on Cancer.

                                                RTI Surgical at a 52-Week High: What's Driving the Stock?

                                                Share price of RTI Surgical, Inc. (RTIX), based in Alachua, FL, scaled a new 52-week high of $6.00 on Jul 10, eventually closing a bit lower at $5.65.

                                                  Neogen Introduces Test for Listeria in Environmental Samples

                                                  Neogen Corporation (NEOG) recently developed Listeria Right Now test system.